GC/MS comparison testing
Every detection chemistry is benchmarked against gas chromatography–mass spectrometry, the laboratory reference method used in forensic toxicology, to confirm sensitivity and specificity before any product reaches the field.
DrugLab118 was the first company to commercialise rapid drink-spiking tests built on laboratory-validated methodologies. Here is how that chemistry is developed, tested, and manufactured.
97–100% agreement with GC/MS. Our detection technology is built on forensic chemistry and published for independent scrutiny. The Drink Detective benzodiazepine strip achieves 97–100% agreement with GC/MS laboratory analysis — the reference standard forensic toxicologists use in court. Our cross-reactivity testing has evaluated over ninety non-drug compounds, with zero false positives.
More substances, more formats. The K+ colorimetric test detects all amine-based illicit substances — including cocaine, heroin, LSD, MDMA, methamphetamine and amphetamine, in addition to ketamine. Our immunoassay strip detects twenty-two benzodiazepines, including Rohypnol. Our FentanylDetective cassette detects fentanyl and nine analogues at greater than 99% reproducibility.
Built for the real world. DrugLab118 holds USA patent protection on both the DrinkDetective and DrugDetective products. We have spent 25 years refining detection technology for the environments where people are most vulnerable — not the laboratory, but the bar, the campus, the festival, and the street.
Every detection chemistry is benchmarked against gas chromatography–mass spectrometry, the laboratory reference method used in forensic toxicology, to confirm sensitivity and specificity before any product reaches the field.
Each test is challenged against 90+ non-drug compounds and more than 50 beverages — common ingredients, sweeteners, and additives — to rule out false positives before manufacturing.
Police forces, customs authorities, and forensic institutes — including Devon & Cornwall Police and Dutch Customs — trial our products in operational settings before we publish results for procurement teams to cite.
DrugLab118's chemistry is developed and produced by SureScreen Diagnostics, a British forensic diagnostics manufacturer. That relationship means every batch is manufactured to the same regulated process, with technical review documents available to institutional buyers.
See the published evidence →We provide the complete evidence pack to institutional buyers on request.
Request the evidence pack →